New chemo sequence aims to extend life in pancreatic cancer
NCT ID NCT05065801
First seen Mar 08, 2026 · Last updated May 14, 2026 · Updated 9 times
Summary
This study tests whether giving two different chemotherapy regimens one after the other (first Gembrax, then Folfirinox) helps people with metastatic pancreatic cancer live longer without their disease getting worse, compared to using Folfirinox alone. About 162 adults aged 18 to 75 with confirmed metastatic pancreatic cancer will take part. The goal is to see if the sequential approach improves progression-free survival while keeping side effects manageable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CH de Perpignan
RECRUITINGPerpignan, Pyrénées-Orientales, 66046, France
Contact Email: •••••@•••••
-
CHU Grenoble
NOT_YET_RECRUITINGGrenoble, Auvergne-Rhône-Alpes, 38000, France
Contact Email: •••••@•••••
-
CHU St Eloi
RECRUITINGMontpellier, Herault, 34295, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU St Etienne
ACTIVE_NOT_RECRUITINGSaint-Etienne, Auvergne-Rhône-Alpes, 42000, France
-
Centre Catalan d'Oncologie
NOT_YET_RECRUITINGPerpignan, Pyrénées-Orientales, 66000, France
Contact Email: •••••@•••••
-
Centre Georges-François Leclerc
RECRUITINGDijon, 21079, France
Contact Email: •••••@•••••
-
Institut GODINOT
RECRUITINGReims, Grand Est, 51100, France
Contact Email: •••••@•••••
-
Institut régional du Cancer de Montpellier
RECRUITINGMontpellier, Hérault, 34298, France
Contact
Contact
Conditions
Explore the condition pages connected to this study.